Avanos Medical, Inc. is projected to rise to $29.96 by 2027, a +20% move from its current price of $24.93. AVNS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $24.71 | $24.94 | $25.17 | +0.03% |
| Jul 13 | $24.62 | $24.95 | $25.27 | +0.06% |
| Jul 14 | $24.56 | $24.95 | $25.35 | +0.09% |
| Jul 15 | $24.51 | $24.96 | $25.42 | +0.12% |
| Jul 16 | $24.46 | $24.97 | $25.49 | +0.15% |
| Jul 17 | $24.42 | $24.98 | $25.55 | +0.18% |
| Jul 18 | $24.38 | $24.98 | $25.60 | +0.21% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $24.38 | $24.98 | $25.60 | +0.21% |
| Week 2 | $24.19 | $25.04 | $25.91 | +0.43% |
| Week 3 | $24.05 | $25.09 | $26.17 | +0.64% |
| Week 4 | $23.95 | $25.14 | $26.40 | +0.86% |
| Week 5 | $23.86 | $25.20 | $26.61 | +1.08% |
| Week 6 | $23.79 | $25.25 | $26.80 | +1.29% |
| Week 7 | $23.73 | $25.31 | $26.99 | +1.51% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Avanos Medical, Inc. is a medical technology company that provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.
Its digestive health products include Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
The company also offers non-opioid pain solutions, including ON-Q and ambIT surgical pain pumps, Game Ready cold and compression therapy systems, interventional pain solutions such as COOLIEF chronic pain products, and Trident and Esentec radiofrequency ablation products.
Avanos Medical, Inc. (AVNS) currently trades at $24.94.
It has a market capitalization of $1.17B and is ranked 2434.
The price outlook is reflected in a year-by-year forecast. In 2026 the avg price is $24.94 with a min of $11.18, a max of $33.30; ROI is 0 and sentiment NEUTRAL.
Forecasts for subsequent years show rising averages and ROIs, including 2027 avg $29.90 (ROI 19.9), 2028 avg $33.05 (ROI 32.5), 2029 avg $35.26 (ROI 41.4), 2030 avg $38.07 (ROI 52.6), and extending through 2050 with 2040 avg $105.88 (ROI 324.6) and 2050 avg $194.50 (ROI 679.9).
A major floor 47.7% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.2% away) — a key level to hold.
Price is pressing into resistance (0.5% away) — a breakout level to watch.
A major ceiling 1.4% above — clearing it would confirm fresh momentum.
Key AVNS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AVNS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $24.93 | Buy | $24.92 | Buy |
| MA 10 | $24.90 | Buy | $24.91 | Buy |
| MA 20 | $24.91 | Buy | $24.88 | Buy |
| MA 50 | $24.85 | Buy | $23.90 | Buy |
| MA 100 | $20.57 | Buy | $21.41 | Buy |
| MA 200 | $16.25 | Buy | $18.49 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.23 | Neutral |
| Stoch RSI (14) | 54.82 | Neutral |
| CCI (20) | 25.32 | Neutral |
| Williams %R (14) | -6.25 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | 0.00 | Neutral |
| Bollinger %B (20,2) | 0.55 | Neutral |
| Stochastic %K (14) | 93.75 | Sell |
| TRIX (15) | 0.06 | Buy |
| Awesome (5,34) | 0.02 | Buy |
| Ultimate (7,14,28) | 52.85 | Neutral |
| Momentum (10) | 0.03 | Buy |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 24.96 | Sell |
| ADX (14) | 35.75 | Buy |
| ATR (14) | 0.06 | Info |
The 30-day technical picture is bullish, with RSI14 at 70.
SMA50 is $24.15 and SMA200 is $15.37. Support is $24.61 and resistance is $25.05. The 30-day price range spans from $23.47 to $26.51.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.18 | $24.93 | $32.37 | 0% | Neutral | |
| $24.54 | $29.96 | $38.25 | +20% | Bullish | |
| $26.98 | $33.56 | $44.00 | +35% | Bullish | |
| $27.66 | $34.94 | $46.78 | +40% | Bullish | |
| $30.20 | $38.66 | $52.70 | +55% | Bullish | |
| $35.22 | $45.64 | $63.19 | +83% | Bullish | |
| $40.67 | $53.30 | $74.85 | +114% | Bullish | |
| $46.47 | $61.54 | $87.54 | +147% | Bullish | |
| $48.06 | $64.28 | $92.54 | +158% | Bullish | |
| $49.62 | $66.99 | $97.51 | +169% | Bullish | |
| $77.44 | $109.04 | $166.33 | +337% | Bullish | |
| $129.71 | $195.90 | $320.31 | +686% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $11.18 | $24.93 | $29.44 | +0.00% |
| August 2026 | $21.27 | $24.90 | $29.79 | -0.11% |
| September 2026 | $21.79 | $25.63 | $30.90 | +2.93% |
| October 2026 | $22.07 | $26.07 | $31.64 | +1.71% |
| November 2026 | $21.84 | $25.89 | $31.59 | -0.70% |
| December 2026 | $22.20 | $26.40 | $32.37 | +1.97% |
Click any year to see its month-by-month AVNS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The AVNS price prediction for 2026 points to an average of $24.93 (low $11.18, high $32.37) — a potential gain of 0% on today's $24.93. A consolidation phase looks the most probable path here.
In 2027, AVNS is projected to trade between $24.54 and $38.25, averaging $29.96 — a potential gain of +20% from today's $24.93. That is up +20% on the projected 2026 average. Momentum favours further upside here.
Avanos Medical, Inc.'s 2028 outlook centres on $33.56, within a $26.98 to $44.00 range. That is up +12% on the projected 2027 average. That marks a +35% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, AVNS could reach as high as $46.78, with a base case around $34.94 and support toward $27.66 — roughly +40% from $24.93. Momentum favours further upside here.
Expect AVNS to range from $30.20 to $52.70 through 2030. The $38.66 average target implies a +55% move from current prices. That is up +11% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The AVNS price prediction for 2031 points to an average of $45.64 (low $35.22, high $63.19) — a potential gain of +83% on today's $24.93. Momentum favours further upside here.
In 2032, AVNS is projected to trade between $40.67 and $74.85, averaging $53.30 — a potential gain of +114% from today's $24.93. That is up +17% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Avanos Medical, Inc.'s 2033 outlook centres on $61.54, within a $46.47 to $87.54 range. That is up +15% on the projected 2032 average. That marks a +147% change versus current levels. Momentum favours further upside here.
By 2034, AVNS could reach as high as $92.54, with a base case around $64.28 and support toward $48.06 — roughly +158% from $24.93. Buyers look set to stay in control over this stretch.
Expect AVNS to range from $49.62 to $97.51 through 2035. The $66.99 average target implies a +169% move from current prices. That is up +4% on the projected 2034 average. Momentum favours further upside here.
The AVNS price prediction for 2040 points to an average of $109.04 (low $77.44, high $166.33) — a potential gain of +337% on today's $24.93. Buyers look set to stay in control over this stretch.
In 2050, AVNS is projected to trade between $129.71 and $320.31, averaging $195.90 — a potential gain of +686% from today's $24.93. That is up +80% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in AVNS today (≈ 40.112314 AVNS) could be worth
$7,857.92
+$6,857.92 (+686%) by 2050 · US Dollar
Based on the average projected AVNS price of $195.9 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AVNSwould be worth at today's price.
$1,000 invested in AVNS on Jul 10, 2025 (≈ 81.566067 AVNS) would be worth
$2,033.44
+$1,033.44 (+103.3%) today · 2.03× · US Dollar
Based on a AVNS entry price of $12.26 vs. today's $24.93.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $24.93 | $1,000 | -0.0% |
| 1 month ago | $24.98 | $998 | -0.2% |
| 3 months ago | $14.18 | $1,758.11 | +75.8% |
| 6 months ago | $11.97 | $2,082.71 | +108.3% |
| 1 year ago | $12.26 | $2,033.44 | +103.3% |
| All time (5.0y) ago | $36.62 | $680.78 | -31.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AVNS forecast.
Our base-case forecast reaches $50.00 around 2032.
Implied market cap at $50.00: $2.34B
In the multi-year forecast, the average price rises over time. In 2027 the avg is $29.90, in 2028 $33.05, in 2029 $35.26, and in 2030 $38.07.
From 2031 to 2035 the forecast shows avg prices of $45.29, $53.56, $59.77, $63.18, and $66.99 with ROIs of 81.6, 114.8, 139.6, 153.3, and 168.6 respectively.
Longer-horizon targets are higher: 2040 avg $105.88 with ROI 324.6 and 2050 avg $194.50 with ROI 679.9, with bullish sentiment in these years.
These figures are estimates, not guarantees, and carry uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $38.07 with a min of $29.72 and a max of $51.94; ROI is 52.6 and sentiment is BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages and ROIs; e.g., 2040 avg $105.88, ROI 324.6 and 2050 avg $194.50, ROI 679.9. These are estimates, not guarantees.
Yes, the 2040 forecast lists a max of $161.58 and an avg of $105.88, with a min of $75.16.
Current price is $24.94; market capitalization is $1.17B.
RSI14 is 70; SMA50 is $24.15; SMA200 is $15.37; support is $24.61; resistance is $25.05; 30-day range is $23.47–$26.51.
Avanos Medical, Inc. Community Discussion
0Share your Avanos Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.